Tammie Thompson
Oncology · Canton, OHNPI 1356445621
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,225 of the $1,682 with a category attached, or 72.8%. It is spread thinly across 27 manufacturers, the largest accounting for just 14.3%. Among oncology clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 62 payments — averaging $27.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$241
- AbbVie$205
- Bayer$129
- Lilly USA, LLC$127
- Novartis$103
- Seagen Inc.$95
- plus $782 from 21 others
What the payments were for
- Food & beverage$1,22573%
- Education$45727%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 5 | $241 |
| AbbVie | 6 | $205 |
| Bayer | 3 | $129 |
| Lilly USA, LLC | 3 | $127 |
| Novartis | 5 | $103 |
| Seagen Inc. | 1 | $95 |
| Johnson & Johnson | 4 | $90 |
| Incyte Corporation | 5 | $88 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $77 |
| Pfizer | 3 | $73 |
| Merck | 4 | $71 |
| Pharmacosmos Therapeutics Inc. | 3 | $55 |
| Astellas Pharma US Inc | 2 | $51 |
| Bristol Myers Squibb | 2 | $35 |
| Genentech USA, Inc. | 1 | $27 |
| Daiichi Sankyo Inc. | 1 | $25 |
| Jazz Pharmaceuticals Inc. | 1 | $21 |
| Tempus AI, Inc | 1 | $20 |
| Gilead | 1 | $19 |
| EMD Serono, Inc. | 1 | $19 |
| Sanofi | 1 | $18 |
| Coherus Oncology, Inc. | 1 | $17 |
| Eisai Inc. | 1 | $16 |
| Taiho Oncology, Inc. | 1 | $16 |
| Deciphera Pharmaceuticals Inc. | 1 | $16 |
| Rigel Pharmaceuticals, Inc. | 1 | $14 |
| G1 Therapeutics, Inc. | 1 | $14 |
How this compares
$1,682 in reported general payments places this provider in the 90th percentile of 20 oncology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TibsovoIvosidenib | 12 | $351,860 |
| ImbruvicaIbrutinib | 12 | $173,899 |
| EliquisApixaban | 15 | $15,617 |
| Anastrozole | 292 | $5,821 |
| Exemestane | 55 | $3,456 |
| Letrozole | 160 | $2,569 |
| Ondansetron Hcl | 40 | $2,235 |
| Tamoxifen Citrate | 33 | $974 |
| Hydroxyurea | 17 | $438 |
| Potassium Chloride | 18 | $259 |
| Dexamethasone | 26 | $236 |
| Acyclovir | 15 | $163 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $145 |
| Alendronate Sodium | 27 | $113 |
| Prednisone | 25 | $80 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $73 | $15,61715 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 20 oncology providers in Ohio.
Other oncology in Canton
- Jill ReeseBeavercreek$7K
- Anne KolenicCleveland$2K
- Shelly BrownColumbus$1K
- Deana KehresSandusky$921
- Patricia AdamsCincinnati$752
- Arleen WuestefeldCincinnati$709
- Deborah WiseKettering$698
- Lisa SmithColumbus$536
- Gail BujorianBarberton$483
- Diana KariusCleveland$464
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.